Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Baodong Sun

Showing results (31-40 of 57) with videos related to

Pageof 6
Sort By:
Molecular Genetics and Metabolism|October 4, 2016
Alglucosidase alfa enzyme replacement therapy as a therapeutic approach for a patient presenting with a PRKAG2 mutationStephanie L Austin, Andrew Chiou, Baodong Sun, et al.
Human Gene Therapy|November 12, 2016
Systemic Correction of Murine Glycogen Storage Disease Type IV by an AAV-Mediated Gene TherapyHaiqing Yi, Quan Zhang, Elizabeth D Brooks, et al.
Molecular Genetics and Metabolism|May 8, 2009
Activation of glycolysis and apoptosis in glycogen storage disease type IaBaodong Sun, Songtao Li, Liu Yang, et al.
Aesthetic Plastic Surgery|June 11, 2005
Management for postoperative complications of breast augmentation by injected polyacrylamide hydrogelQun Qiao, Xiancheng Wang, Jiaming Sun, et al.
Scientific Reports|September 16, 2017
IL-37 is associated with osteoarthritis disease activity and suppresses proinflammatory cytokines production in synovial cellsLiping Ding, Xiaoping Hong, Baodong Sun, et al.
Disease Models & Mechanisms|June 28, 2012
Characterization of a canine model of glycogen storage disease type IIIaHaiqing Yi, Beth L Thurberg, Sarah Curtis, et al.
Cancer Research|February 7, 2002
Targeted cytotoxic somatostatin analogue AN-238 inhibits somatostatin receptor-positive experimental colon cancers independently of their p53 statusKaroly Szepeshazi, Andrew V Schally, Gabor Halmos, et al.
Molecular Genetics and Metabolism|January 4, 2026
Novel promoters drive therapeutic transgene expression and evade transgene-specific immune responses in a mouse model of Pompe diseaseBaodong Sun, Haiqing Yi, Sang-Oh Han, et al.
Journal of Inherited Metabolic Disease|July 8, 2023
Gene therapy for glycogen storage diseasesDwight D Koeberl, Rebecca L Koch, Jeong-A Lim, et al.
International Journal of Cancer|April 7, 2011
Overexpression of the dynein light chain km23-1 in human ovarian carcinoma cells inhibits tumor formation in vivo and causes mitotic delay at prometaphase/metaphaseNageswara R Pulipati, Qunyan Jin, Xin Liu, et al.
Pageof 6

Showing results (31-40 of 57) with videos related to

Sort By:
Pageof 6
Molecular Genetics and Metabolism|October 4, 2016
Alglucosidase alfa enzyme replacement therapy as a therapeutic approach for a patient presenting with a PRKAG2 mutationStephanie L Austin, Andrew Chiou, Baodong Sun, et al.
Human Gene Therapy|November 12, 2016
Systemic Correction of Murine Glycogen Storage Disease Type IV by an AAV-Mediated Gene TherapyHaiqing Yi, Quan Zhang, Elizabeth D Brooks, et al.
Molecular Genetics and Metabolism|May 8, 2009
Activation of glycolysis and apoptosis in glycogen storage disease type IaBaodong Sun, Songtao Li, Liu Yang, et al.
Aesthetic Plastic Surgery|June 11, 2005
Management for postoperative complications of breast augmentation by injected polyacrylamide hydrogelQun Qiao, Xiancheng Wang, Jiaming Sun, et al.
Scientific Reports|September 16, 2017
IL-37 is associated with osteoarthritis disease activity and suppresses proinflammatory cytokines production in synovial cellsLiping Ding, Xiaoping Hong, Baodong Sun, et al.
Disease Models & Mechanisms|June 28, 2012
Characterization of a canine model of glycogen storage disease type IIIaHaiqing Yi, Beth L Thurberg, Sarah Curtis, et al.
Cancer Research|February 7, 2002
Targeted cytotoxic somatostatin analogue AN-238 inhibits somatostatin receptor-positive experimental colon cancers independently of their p53 statusKaroly Szepeshazi, Andrew V Schally, Gabor Halmos, et al.
Molecular Genetics and Metabolism|January 4, 2026
Novel promoters drive therapeutic transgene expression and evade transgene-specific immune responses in a mouse model of Pompe diseaseBaodong Sun, Haiqing Yi, Sang-Oh Han, et al.
Journal of Inherited Metabolic Disease|July 8, 2023
Gene therapy for glycogen storage diseasesDwight D Koeberl, Rebecca L Koch, Jeong-A Lim, et al.
International Journal of Cancer|April 7, 2011
Overexpression of the dynein light chain km23-1 in human ovarian carcinoma cells inhibits tumor formation in vivo and causes mitotic delay at prometaphase/metaphaseNageswara R Pulipati, Qunyan Jin, Xin Liu, et al.
Pageof 6